

554699 ·
BDB Bioscience · Cat: 554699
Reach 3+ verified distributors
Manufacturer product page
bdbiosciences.com/en-us/products/reagents/immunoassay-reagen...Description
Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control. Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control. Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control. Show More Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control. Show More Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control. Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control.